Form 4: Celestica CEO Robert Mionis Executes Stock Sale

Celestica CEO Robert Mionis sold 17,360 common shares via a pre-arranged Rule 10b5-1 trading plan.

Summary

• CEO Robert Mionis sold a total of 17,360 common shares of Celestica Inc. (CLS) on June 17, 2026.
• The transactions were executed at weighted average prices ranging from $378.37 to $392.11 per share.
• All sales were conducted pursuant to a Rule 10b5-1 trading plan adopted on March 11, 2026.
• Following these transactions, the reporting person retains significant holdings, including 453,697 shares held directly and additional shares held in various GRATs.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event; the sale is a routine, pre-planned divestment by an executive and does not indicate a change in company strategy or financial health.

Positives

• The sale was conducted under a pre-established Rule 10b5-1 plan, which is a standard mechanism for executives to sell shares without triggering insider trading concerns.

Negatives

• The sale represents a reduction in the CEO's direct and indirect equity stake in the company.

Risks

• Executive stock sales can sometimes be perceived negatively by the market as a signal of potential future performance concerns, though this sale was pre-planned.

Future Outlook

No specific forward-looking guidance regarding company operations was provided in this filing.

Industry Context

StockSavvy.ai notes that executive selling via 10b5-1 plans is a routine corporate governance practice in the electronics manufacturing services (EMS) sector, often used for personal financial planning rather than reflecting a change in outlook on company performance.

Comparison to Industry Standards

• The use of Rule 10b5-1 plans is the industry standard for executives at major technology firms like Jabil or Flex to manage equity compensation.
• The volume of shares sold relative to the CEO's total holdings remains consistent with standard wealth diversification practices.

Stakeholder Impact

• Minimal impact expected as the sale was pre-planned and executed through a transparent regulatory mechanism.

Next Steps

• Continued monitoring of future Form 4 filings for further insider activity.

Key Dates

Keywords

Celestica, CLS, Insider Trading, Form 4, Robert Mionis, Stock Sale, Rule 10b5-1